Growth Hormone Treatment Response: Associated Factors and Stimulated Growth Hormone Secretion Indices in Prepubertal

Aristeidis Giannakopoulos1, Eleni Kallimani1, Alexandra Efthymiadou1

  • 1Department of Pediatrics, Division of Endocrinology, Medical School, University of Patras, Patras, Greece.

Insights

Age and midparental height are key predictors for growth hormone (GH) treatment response in children with GH deficiency. Maximum GH secretion (GHmax) is the most significant predictor among GH secretory indexes.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Biochemical Markers

Background:

  • Idiopathic growth hormone (GH) deficiency affects prepubertal children, necessitating effective treatment strategies.
  • Growth hormone (GH) replacement therapy is a standard treatment for GH deficiency.
  • Predicting treatment response is crucial for optimizing therapeutic outcomes.

Purpose of the Study:

  • To investigate the correlation between initial clinical and biochemical parameters and growth response in prepubertal children with GH deficiency after one year of GH treatment.
  • To analyze GH secretion dynamics from GH stimulation tests in relation to GH treatment response.
  • To identify the best predictors of recombinant human GH (rhGH) treatment response.

Main Methods:

  • Retrospective analysis of 84 prepubertal children (47 males, 37 females) diagnosed with GH deficiency.
  • Evaluation of GH secretory indexes: GHmax, GH secretion rate, and GH secretion volume.
  • Correlation and regression models to determine predictors of the index of responsiveness (IoR) to rhGH treatment.

Main Results:

  • IoR showed a negative correlation with age (r=-0.607, p<0.01) and positive correlations with the distance from midparental height (MPH) (r=0.466, p<0.01) and pretreatment growth velocity (r=0.247, p<0.05).
  • GHmax demonstrated the strongest association with GH secretion volume (r=0.883, p<0.01).
  • GHmax was the best predictor of IoR (β=-0.514, p<0.001), followed by GH secretion volume (β=-0.47, p<0.001) and GH secretion rate (β=-0.367, p<0.001).

Conclusions:

  • Child's age and the deviation of their height from MPH are significant predictors of GH treatment response in idiopathic GH deficiency.
  • GHmax is a more reliable predictor of GH treatment response than other GH secretory indexes like GHSR and GHSV.
  • Combining clinical and biochemical markers may enhance the pretreatment assessment of rhGH treatment response.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
231
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
318